Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Kiser

Concepts (358)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
32
2025
704
6.360
Why?
Anti-HIV Agents
35
2025
747
4.630
Why?
HIV Infections
56
2025
2703
4.440
Why?
Hepatitis C
13
2023
233
4.330
Why?
Adenine
29
2025
255
4.260
Why?
Hepatitis C, Chronic
14
2025
153
4.050
Why?
Ribavirin
15
2020
92
3.840
Why?
Sofosbuvir
13
2025
58
3.780
Why?
Drug Interactions
21
2019
360
3.370
Why?
Tenofovir
30
2025
231
3.320
Why?
Tandem Mass Spectrometry
17
2025
450
2.450
Why?
Hepacivirus
11
2025
234
2.010
Why?
Dried Blood Spot Testing
13
2024
91
1.950
Why?
Proline
5
2019
78
1.890
Why?
Organophosphates
15
2025
120
1.820
Why?
Oligopeptides
8
2015
257
1.810
Why?
Emtricitabine
19
2025
168
1.780
Why?
Organophosphonates
12
2014
91
1.600
Why?
Ritonavir
8
2021
72
1.470
Why?
Protease Inhibitors
4
2020
103
1.420
Why?
Chromatography, Liquid
14
2025
374
1.350
Why?
Coinfection
5
2024
131
1.330
Why?
Benzimidazoles
6
2025
158
1.240
Why?
Phosphorous Acids
3
2019
13
1.220
Why?
Fluorenes
4
2020
40
1.120
Why?
Pyrophosphatases
3
2016
21
1.100
Why?
Hepatitis B
4
2024
61
1.080
Why?
Nucleotides
3
2016
117
1.080
Why?
Medication Adherence
16
2022
573
0.970
Why?
Anti-Retroviral Agents
5
2019
230
0.950
Why?
Drug Therapy, Combination
12
2018
1009
0.880
Why?
Pyridines
5
2015
469
0.860
Why?
Humans
101
2025
128524
0.790
Why?
Polyphosphates
7
2022
37
0.790
Why?
Erythrocytes
8
2016
670
0.790
Why?
Cell Phone
1
2022
70
0.770
Why?
HIV Protease Inhibitors
5
2011
61
0.760
Why?
Reverse Transcriptase Inhibitors
5
2014
81
0.760
Why?
Viral Load
11
2024
450
0.740
Why?
Membrane Transport Proteins
4
2016
148
0.730
Why?
Simeprevir
2
2018
8
0.730
Why?
HIV-1
7
2021
840
0.710
Why?
Sulfonamides
5
2019
500
0.700
Why?
Mobile Applications
1
2022
158
0.680
Why?
Therapies, Investigational
1
2019
14
0.660
Why?
Heterocyclic Compounds, 3-Ring
2
2023
30
0.630
Why?
Respiratory Syncytial Virus Infections
1
2020
117
0.630
Why?
Adult
45
2025
35315
0.610
Why?
Leukocytes, Mononuclear
9
2025
538
0.610
Why?
Male
55
2025
62883
0.610
Why?
Ethanol
1
2023
585
0.600
Why?
Middle Aged
39
2025
30893
0.600
Why?
Pyridazines
2
2021
50
0.590
Why?
Antiretroviral Therapy, Highly Active
4
2015
266
0.580
Why?
Lung Transplantation
1
2020
275
0.580
Why?
Solid Phase Extraction
2
2014
20
0.570
Why?
Pyrimidinones
2
2008
102
0.550
Why?
Liver
2
2016
1827
0.540
Why?
HIV Integrase Inhibitors
1
2018
70
0.540
Why?
Inosine
1
2016
12
0.540
Why?
Guanosine
1
2016
40
0.530
Why?
Pharmacogenomic Variants
1
2016
35
0.520
Why?
Female
50
2025
68127
0.510
Why?
Chromatography, High Pressure Liquid
2
2015
475
0.510
Why?
Purines
1
2016
169
0.500
Why?
Drug Monitoring
3
2022
184
0.490
Why?
Carbamates
2
2025
45
0.490
Why?
Drug Discovery
1
2016
130
0.490
Why?
Isoniazid
2
2012
60
0.480
Why?
Serum
1
2015
56
0.470
Why?
Kidney
4
2016
1305
0.470
Why?
Adenosine
1
2016
211
0.470
Why?
Intracellular Space
1
2014
71
0.460
Why?
Pre-Exposure Prophylaxis
5
2020
202
0.450
Why?
Telemedicine
1
2022
778
0.440
Why?
HIV
4
2019
226
0.440
Why?
Priapism
1
2013
9
0.440
Why?
Receptors, Adrenergic, alpha
1
2013
25
0.440
Why?
Adrenergic alpha-Antagonists
1
2013
32
0.440
Why?
Deoxycytidine
6
2017
164
0.430
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
20
0.430
Why?
Antitubercular Agents
2
2012
197
0.430
Why?
Hepatitis B, Chronic
3
2022
18
0.400
Why?
Hepatitis B virus
4
2024
35
0.400
Why?
Treatment Outcome
13
2025
10163
0.400
Why?
Gastric Bypass
1
2014
107
0.400
Why?
Alanine
5
2025
141
0.370
Why?
Prospective Studies
17
2022
7043
0.370
Why?
Phenotype
2
2016
3050
0.360
Why?
HIV Seronegativity
1
2010
25
0.360
Why?
Antacids
1
2010
13
0.360
Why?
Pyrrolidinones
1
2010
29
0.350
Why?
Genotype
6
2023
1831
0.350
Why?
Pyrimidines
3
2021
444
0.350
Why?
Patient Compliance
3
2017
562
0.340
Why?
Tuberculosis
2
2012
275
0.330
Why?
Pregnancy Complications, Infectious
3
2025
335
0.330
Why?
Pharmacy Service, Hospital
1
2011
93
0.330
Why?
Plasma
4
2016
201
0.330
Why?
Blood Chemical Analysis
4
2019
96
0.330
Why?
Reproducibility of Results
8
2016
3023
0.320
Why?
Area Under Curve
4
2018
281
0.320
Why?
Uridine Monophosphate
2
2019
15
0.310
Why?
Drug Prescriptions
1
2011
250
0.310
Why?
Young Adult
17
2025
12320
0.300
Why?
Fluorobenzenes
1
2008
15
0.300
Why?
Adolescent
20
2020
20213
0.290
Why?
Drug Stability
5
2016
144
0.290
Why?
Guidelines as Topic
1
2009
260
0.280
Why?
Atazanavir Sulfate
5
2015
41
0.280
Why?
Liver Transplantation
1
2014
795
0.270
Why?
Sensitivity and Specificity
5
2014
1820
0.270
Why?
Half-Life
3
2015
144
0.270
Why?
Esomeprazole
1
2006
6
0.260
Why?
Anti-Ulcer Agents
1
2006
14
0.260
Why?
Glycerophospholipids
2
2023
32
0.260
Why?
Pharmacology, Clinical
1
2006
9
0.260
Why?
Sustained Virologic Response
3
2023
36
0.250
Why?
Hepatocytes
3
2016
213
0.250
Why?
Education
1
2006
99
0.250
Why?
Heterocyclic Compounds, 4 or More Rings
1
2025
19
0.240
Why?
Proton Pump Inhibitors
1
2006
98
0.240
Why?
South Africa
4
2015
192
0.240
Why?
Phosphates
3
2015
167
0.230
Why?
Anemia
2
2016
156
0.220
Why?
Biomarkers
5
2023
3881
0.220
Why?
Health Personnel
1
2009
646
0.210
Why?
Variola virus
1
2022
1
0.210
Why?
Smallpox
1
2022
8
0.210
Why?
World Health Organization
1
2022
109
0.200
Why?
Delivery of Health Care
1
2009
892
0.200
Why?
Blood Platelets
1
2025
369
0.190
Why?
Linear Models
2
2014
816
0.190
Why?
Cross-Over Studies
4
2020
513
0.190
Why?
Cyclopropanes
2
2019
88
0.190
Why?
Lopinavir
3
2020
30
0.190
Why?
Point-of-Care Systems
1
2023
150
0.180
Why?
Dideoxynucleosides
2
2023
20
0.180
Why?
Phosphorylation
2
2015
1681
0.180
Why?
Interferons
2
2019
192
0.170
Why?
Aminoisobutyric Acids
1
2019
7
0.170
Why?
Drug Administration Schedule
3
2019
757
0.170
Why?
Neutrophils
1
2025
1188
0.160
Why?
Lactams, Macrocyclic
1
2019
49
0.160
Why?
Homosexuality, Male
2
2017
176
0.160
Why?
Pyrrolidines
1
2019
64
0.160
Why?
Quinoxalines
1
2019
65
0.160
Why?
Leucine
1
2019
108
0.160
Why?
Nucleic Acids
1
2019
60
0.160
Why?
Quality Control
2
2015
156
0.150
Why?
Organic Anion Transport Protein 1
2
2008
6
0.150
Why?
Oxazines
1
2018
26
0.150
Why?
Multidrug Resistance-Associated Proteins
2
2008
36
0.150
Why?
Directly Observed Therapy
1
2017
14
0.140
Why?
Bronchoalveolar Lavage Fluid
1
2020
626
0.140
Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
17
0.140
Why?
Nitriles
2
2021
160
0.140
Why?
Liver Cirrhosis
1
2019
273
0.140
Why?
Pregnancy Outcome
1
2020
383
0.140
Why?
Pharmacogenetics
2
2016
171
0.140
Why?
Inosine Triphosphate
1
2016
3
0.140
Why?
Anemia, Hemolytic
1
2016
17
0.140
Why?
Darunavir
2
2014
17
0.140
Why?
Deoxyadenine Nucleotides
1
2016
13
0.140
Why?
Deoxycytosine Nucleotides
1
2016
11
0.140
Why?
Guanosine Triphosphate
1
2016
92
0.130
Why?
Glass
1
2016
43
0.130
Why?
Pharmacy
1
2017
32
0.130
Why?
Drug Combinations
3
2025
323
0.130
Why?
Molecular Targeted Therapy
1
2019
387
0.130
Why?
Zika Virus
1
2017
77
0.130
Why?
Genitalia
1
2016
30
0.130
Why?
Syringes
1
2016
37
0.130
Why?
Disease Transmission, Infectious
1
2017
57
0.130
Why?
Drug Packaging
1
2016
41
0.130
Why?
Drug and Narcotic Control
1
2016
28
0.130
Why?
Viremia
3
2022
130
0.130
Why?
Pyridones
1
2018
159
0.130
Why?
Fibroblast Growth Factors
2
2014
171
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
411
0.120
Why?
Polymers
1
2019
471
0.120
Why?
Analgesics
1
2017
165
0.120
Why?
Retrospective Studies
4
2020
14460
0.120
Why?
Practice Guidelines as Topic
2
2016
1490
0.120
Why?
Piperazines
1
2018
334
0.120
Why?
Biological Assay
1
2016
118
0.120
Why?
Cytosol
1
2016
213
0.120
Why?
Polymorphism, Single Nucleotide
2
2016
2065
0.120
Why?
Rectum
1
2016
169
0.120
Why?
Creatinine
2
2018
475
0.120
Why?
Brain Diseases
1
2016
134
0.120
Why?
Population
1
2015
33
0.120
Why?
Nonlinear Dynamics
1
2015
88
0.120
Why?
Mental Health Services
1
2019
399
0.120
Why?
Chemical and Drug Induced Liver Injury
1
2016
134
0.120
Why?
Virus Replication
1
2017
444
0.120
Why?
Liver Function Tests
1
2015
109
0.120
Why?
CD4 Lymphocyte Count
2
2015
265
0.110
Why?
Infectious Disease Transmission, Vertical
3
2025
165
0.110
Why?
Administration, Oral
3
2019
757
0.110
Why?
Pharmaceutical Preparations
1
2016
170
0.110
Why?
Adenosine Triphosphate
1
2016
470
0.110
Why?
Least-Squares Analysis
1
2014
72
0.110
Why?
Pharmacists
1
2017
262
0.110
Why?
Infant
5
2020
8913
0.110
Why?
Metabolic Clearance Rate
2
2018
103
0.110
Why?
Hypophosphatemia
1
2013
15
0.110
Why?
Cholecalciferol
1
2014
57
0.110
Why?
Double-Blind Method
3
2013
1860
0.110
Why?
Liver Diseases
1
2016
285
0.110
Why?
Diphosphates
3
2021
17
0.110
Why?
Calcitriol
1
2013
55
0.100
Why?
Cytochrome P-450 CYP3A
1
2013
66
0.100
Why?
Tablets
2
2023
37
0.100
Why?
Leukocytes
1
2014
303
0.100
Why?
Desiccation
1
2012
20
0.100
Why?
Monocytes
1
2015
541
0.100
Why?
Kidney Diseases
1
2016
368
0.100
Why?
Case-Control Studies
3
2024
3326
0.100
Why?
Diabetes Mellitus
1
2020
1001
0.100
Why?
Organic Anion Transporters
1
2011
10
0.100
Why?
Benzoxazines
1
2012
31
0.100
Why?
Pravastatin
1
2011
26
0.100
Why?
Levonorgestrel
1
2012
37
0.100
Why?
Child, Preschool
4
2021
10373
0.090
Why?
Arylamine N-Acetyltransferase
1
2011
5
0.090
Why?
Benchmarking
2
2024
176
0.090
Why?
Vitamin D Deficiency
1
2013
177
0.090
Why?
Nucleosides
1
2011
26
0.090
Why?
Specimen Handling
1
2012
165
0.090
Why?
Interferon-alpha
1
2012
192
0.090
Why?
Mental Disorders
1
2019
1007
0.090
Why?
Contraceptive Agents, Female
1
2012
78
0.090
Why?
Models, Statistical
1
2015
625
0.090
Why?
Raltegravir Potassium
1
2010
17
0.090
Why?
Hospitals, University
1
2011
175
0.090
Why?
Body Weight
1
2015
931
0.090
Why?
Patient Acceptance of Health Care
1
2017
764
0.090
Why?
Sex Distribution
1
2011
359
0.080
Why?
Cohort Studies
2
2019
5369
0.080
Why?
Aged
5
2018
21971
0.080
Why?
Sex Characteristics
1
2015
727
0.080
Why?
Dietary Supplements
1
2014
529
0.080
Why?
Mycobacterium tuberculosis
1
2012
314
0.080
Why?
Time Factors
4
2016
6503
0.080
Why?
Lamivudine
2
2023
61
0.080
Why?
Rosuvastatin Calcium
1
2008
20
0.070
Why?
Immunosuppressive Agents
1
2012
686
0.070
Why?
Pregnancy
4
2025
6297
0.070
Why?
Kidney Calculi
1
2007
35
0.070
Why?
Portugal
1
2006
10
0.070
Why?
Gene Frequency
1
2008
504
0.070
Why?
Education, Medical
1
2009
244
0.060
Why?
Quebec
1
2006
10
0.060
Why?
Furans
1
2006
22
0.060
Why?
Self Report
2
2021
801
0.060
Why?
Dementia
1
2009
227
0.060
Why?
Referral and Consultation
1
2011
727
0.060
Why?
Benzopyrans
1
2025
31
0.060
Why?
Sexual and Gender Minorities
2
2019
186
0.060
Why?
Internationality
1
2006
148
0.060
Why?
United States
4
2017
13876
0.060
Why?
Hematocrit
2
2016
94
0.060
Why?
Child
4
2021
20721
0.060
Why?
Lipids
1
2008
624
0.060
Why?
Predictive Value of Tests
2
2019
1936
0.060
Why?
Isoindoles
1
2022
4
0.050
Why?
Monkeypox virus
1
2022
13
0.050
Why?
Risk Assessment
1
2012
3256
0.050
Why?
Calibration
2
2013
135
0.050
Why?
Benzamides
1
2022
194
0.050
Why?
Demography
1
2022
277
0.050
Why?
Animals
4
2022
34501
0.050
Why?
Treatment Failure
1
2023
342
0.050
Why?
Computer Simulation
2
2016
939
0.050
Why?
Temperature
2
2016
625
0.050
Why?
Drug Approval
1
2020
86
0.040
Why?
Tissue Donors
1
2023
386
0.040
Why?
Dose-Response Relationship, Drug
2
2016
1943
0.040
Why?
Lactation
1
2020
170
0.040
Why?
Models, Biological
2
2016
1693
0.040
Why?
Developing Countries
1
2020
283
0.040
Why?
Chemistry Techniques, Analytical
1
2018
19
0.040
Why?
Flaviviridae
1
2017
5
0.040
Why?
Vero Cells
1
2017
66
0.040
Why?
Drug Repositioning
1
2017
25
0.040
Why?
Inhibitory Concentration 50
1
2017
81
0.040
Why?
A549 Cells
1
2017
58
0.040
Why?
Hair
1
2018
74
0.040
Why?
Pharmaceutical Solutions
1
2016
14
0.030
Why?
Patient Selection
1
2020
661
0.030
Why?
Breast Feeding
1
2020
421
0.030
Why?
Chromatography, Reverse-Phase
1
2016
27
0.030
Why?
Drug Storage
1
2016
53
0.030
Why?
Cities
1
2017
104
0.030
Why?
Alcohol Drinking
1
2023
749
0.030
Why?
Defective Viruses
1
2016
5
0.030
Why?
Acute Disease
1
2019
968
0.030
Why?
Drug Compounding
1
2016
95
0.030
Why?
Solubility
1
2016
229
0.030
Why?
Methanol
1
2016
33
0.030
Why?
Spermatozoa
1
2016
91
0.030
Why?
Clinical Trials as Topic
1
2020
998
0.030
Why?
Solutions
1
2016
147
0.030
Why?
Cold Temperature
1
2016
151
0.030
Why?
Blood-Brain Barrier
1
2016
129
0.030
Why?
Hydrogen-Ion Concentration
1
2016
538
0.030
Why?
Pregnancy Complications
1
2020
488
0.030
Why?
Administration, Inhalation
1
2016
664
0.030
Why?
Comorbidity
1
2019
1540
0.030
Why?
Logistic Models
1
2020
1975
0.030
Why?
Risk-Taking
1
2017
348
0.030
Why?
Interleukins
1
2016
242
0.030
Why?
DNA, Viral
1
2016
348
0.030
Why?
Recurrence
1
2017
1001
0.030
Why?
Feasibility Studies
1
2017
860
0.030
Why?
Vitamin D-Binding Protein
1
2013
15
0.030
Why?
Mental Health
1
2019
684
0.030
Why?
Algorithms
1
2020
1616
0.030
Why?
Parathyroid Hormone
1
2013
106
0.030
Why?
Water
1
2016
444
0.020
Why?
Therapeutic Equivalency
1
2012
20
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
255
0.020
Why?
Alkynes
1
2012
54
0.020
Why?
Cell Line
1
2017
2731
0.020
Why?
Anion Exchange Resins
1
2011
7
0.020
Why?
Zidovudine
1
2011
77
0.020
Why?
Food-Drug Interactions
1
2010
8
0.020
Why?
Reference Standards
1
2011
170
0.020
Why?
Longitudinal Studies
1
2018
2697
0.020
Why?
Chemoprevention
1
2010
89
0.020
Why?
Latent Tuberculosis
1
2011
68
0.020
Why?
Epithelial Cells
1
2016
1036
0.020
Why?
Haplotypes
1
2011
471
0.020
Why?
Cholesterol
1
2011
406
0.020
Why?
Glomerular Filtration Rate
1
2013
681
0.020
Why?
Triglycerides
1
2011
524
0.020
Why?
Infant, Newborn
1
2020
5687
0.020
Why?
AIDS Dementia Complex
1
2009
51
0.020
Why?
Polymorphism, Genetic
1
2011
639
0.020
Why?
Follow-Up Studies
1
2017
4898
0.020
Why?
Cross-Sectional Studies
1
2019
5040
0.020
Why?
Acquired Immunodeficiency Syndrome
1
2009
222
0.020
Why?
Positron-Emission Tomography
1
2009
281
0.020
Why?
Antiemetics
1
1987
39
0.020
Why?
Calcium
1
2013
1178
0.020
Why?
Vomiting
1
1987
128
0.020
Why?
Gene Expression Regulation
1
2016
2506
0.020
Why?
Aged, 80 and over
1
2018
7040
0.020
Why?
Neuropsychological Tests
1
2009
1003
0.010
Why?
Brain
1
2016
2618
0.010
Why?
Age Factors
1
2011
3117
0.010
Why?
Alzheimer Disease
1
2009
515
0.010
Why?
Magnetic Resonance Imaging
1
2009
3366
0.010
Why?
Antineoplastic Agents
1
1987
2058
0.010
Why?
Flunitrazepam
1
1987
3
0.000
Why?
Metoclopramide
1
1987
17
0.000
Why?
Methylprednisolone
1
1987
82
0.000
Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)